medigraphic.com
ISSN 1561-3119 (Electronic)

2021, Number 2

<< Back Next >>

Rev Cubana Pediatr 2021; 93 (2)

Outlier adenic toxoplasmic syndrome

Zayas MIG, Mestre VP, Pantoja PO, González RZ

Language: Spanish
References: 31
Page: 1-11
PDF size: 429.91 Kb.


ABSTRACT

Introduction: Adenopathies, lymphadenopathies or lymphadenomegalies are common causes of pediatric consultation. These nosological entities can range from transient benign infections to malignant processes such as lymphoma, tumor metastases, and others.
Objective: Describe a clinical case with an adenic syndrome that from the semiological characteristics suggested an onco-proliferative process and the results of the complementary studies confirmed an infectious process caused by Toxoplasma gondii.
Case presentation: 11-year-old female adolescent, eutrophic, with a personal health history. She was admitted at "William Soler" University Pediatric Hospital after presenting volume increase in the right lateral cervical region. An adenopathy of approximately 2 x 3 cm in diameter, hard, motionless, non-painful, with no signs of inflammation, not attached to deep planes was found at the physical examination; in the evolution, another adenopathy appeared in a lower right cervical position, with equal characteristics. Blood counts, globular sedimentation rate, C-reactive protein, transaminases, glycemia, total proteins, albumin, triglycerides, cholesterol, tumor markers, ultrasound, chest x-rays, serology for anti-cytomegalovirus antibodies, human immunodeficiency virus and Toxoplasma gondii tests were indicated. Biopsy was also performed for study by pathological anatomy and molecular biology. The case was concluded as an adenic toxoplasmic syndrome.
Conclusions: In adolescent patients with cervical adenopathies, regardless of size, evolution time and consistency, differential diagnosis for Toxoplasma gondii infection should be made, taking into account that adenopathies caused by this parasite may have some characteristics similar to those caused by onco-proliferative processes that may occur at this age.


REFERENCES

  1. Özkan EA, Göret CC, Özdemir ZT, Yanik S, Goret Emrah N , Dogan M, et al. Evaluation of peripheral lymphadenopathy with excisional biopsy: sixyear experience. Int J Clin Exp Pathol. 2015; 8:15234-15239.

  2. Gómez E, Giraldob LM, Espinala DA, Hurtado IC. Características clínicas e histológicas de adenopatías en pacientes pediátricos. Rev Chil Pediatr. 2016;87:255-60.

  3. Deosthali A, Donches K, Del Vecchio M, Aronoff F. Etiologies of Pediatric Cervical Lymphadenopathy: A Systematic Review of 2687 Subjects. Glob Pediatr Health. 2019 6:1-7.

  4. Del Rosal T, Baquero F. Adenitis cervical. Pediatr Integral. 2018;22:307-15.

  5. Tower RL, Camitta BM. Linfadenopatía. Nelson. Tratado de Pediatría. 20ª ed. Madrid: Elsevier España; 2016.

  6. Rojo Conejo P, González Granado I, Fernández Cooke E. Adenitis cervical. Infectología pediátrica básica. Manejo práctico. Madrid: Editorial Médica Panamericana; 2012.

  7. Weinstock MS, Patel NA, Smith LP. Pediatric Cervical Lymphadenopathy. Pediatric Rev.2018; 39:433-43.

  8. Raluy Domínguez JJ. Adenopatías. AMF. 2011;7:218-22.

  9. Vigué MG, Saumet Sirvent N, Jeziorski E. Diagnóstico de las adenopatías superficiales en el niño. EMC-Pediatr. 2018;53:1-7

  10. Reyes-Cadena A. Linfadenopatía cervical. Acta Pediatr Méx. 2017;38:208-14.

  11. Chaves MO. Patología linfática de adenopatías en niños. Rev Med Costa Rica Centroam LXXIII. 2016;618:37-40.

  12. Ferrís i Tortajada J, García I Castell J, Barberá Domingo MP, López Andreu JA, Guillén Fontalba E, Gisbert Aguilar FJ. Semiología de las adenopatías en Pediatría. Puesta al día. Valencia: Hospital Infantil "La Fe", Unidad de oncología; 1998.

  13. De Armas Y, Friaza V, Capó V, Govín A, Durand-Jolly I, de la Horra C, et al. Low genetic diversity of Pneumocystis jirovecii among. Cuban population based on two-locus mitochondrial typing. Med Mycol. 2012;50:417-20.

  14. Fraga J, Alfonso Y. Diagnóstico de la Toxoplasmosis. Rev Ciencias. 2006;3:210-25.

  15. Kartala O, Atasa E, Gürsela O. Diferenciación entre linfadenopatía cervical benigna y maligna mediante ecografía en niños. Arch Argent Pediatr. 2020;118:11-7.

  16. Chiappini E, Camaioni A, Benazoo M. Development of an algorithm for the management of cervical lymphadenopathyin children: consensus of the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Society of Pediatric Infectious Diseases and the Italian Society of Pediatric Otorhinolaryngology. Expert Rev Anti Infect Ther. 2015;11:1557-67.

  17. Vargas Viveros M. Adenomegalia. Rev Fac Med UNAM. 2011;54:10-23.

  18. Rosales Oliva A, Rosales Oliva M, Mendoza Galán O. Infección por Toxoplasma gondii en un adolescente. Medisan. 2016;20:73-6.

  19. Penn EB, Goudy SL. Pediatric Inflammatory Adenopathy. Otolaryng Clin N Am. 2015;48:137-51.

  20. González D, Montoto V. Seroprevalencia de anticuerpos IgG anti-toxoplasma gondii. Rev Cubana Tecnol Salud. 2018;9:25-35.

  21. Cofré F, Delpiano L, Labraña Y, Reyes A, Sandoval AI, zquierdo G. Síndrome de TORCH: enfoque racional del diagnóstico y tratamiento pre y post natal. Rev Chilena Infectol. 2016;33:191-216.

  22. Del Castillo Martín F, Funes Moñux RM, Gutiérrez Juárez J, Serrano JL. Linfadenitis por toxoplasmosis aguda adquirida. An Esp Pediat. 1998;49:65-7.

  23. San Miguel M, Baldeón Cuencab K, Bermejo Ruiz E, Bustamante Odriozolad J. Toxoplasmosis ganglionar. Semergen. 2017;43:539.

  24. Reyes-Cadena A. Linfadenopatía cervical. Acta Pediatr Mex. 2017;38:208-14.

  25. Alfonso Y, Fraga J, Jiménez N, Fonseca C, Dorta-Contreras AJ. Detection of Toxoplasma gondii in cerebrospinal fluid from AIDS patients by nested PCR and rapid identification of type I allele at B1 gene by RFLP analysis. Exp Parasitol. 2009;122:203-7.

  26. Apt W, Thiermam E, Niedman G, Pasmanik S. Toxoplasmosis. Santiago: Ed. Universidad de Chile press; 1973.

  27. Derouin F, Rabian-Herzog C, Sulahian A. Longitudinal studies of the specific humoral and cellular responses to Toxoplasma gondii in a patient with acquiered toxoplasmosis. J Clin Lab Immunol. 1989;30:97-102.

  28. Saxén L, Saxén E, Tenhunen A. The significance of histological diagnosis in glandular toxoplasmosis. Acta Pathol Microbiol Scand. 1962;56 284-92.

  29. Dorfman RF, Remington JS. Value of lymph node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med. 1973;289:878-81.

  30. Langoni H, Das Dores CB, Silva RC, Pezerico SB, Castro AP. Detection of Toxoplasma gondii DNA in sera samples of Mice Experimentally Infected. J Venom Anim Toxins incl Trop Dis. 2006;12:202-14.

  31. Gashout A, Amro A, Erhuma M, Al-Dwibe H, Elmaihub E. Molecular diagnosis of Toxoplasma gondii infection in Libya. BMC Infect Dis.2016;16:157.




2020     |     www.medigraphic.com